Fibrin Sealants Market Trends

  • Report ID: 4466
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Fibrin Sealants Market Trends

Growth Drivers

  • Worldwide Growing Count of Surgical Procedures - A wide range of medical disorders are diagnosed, or treated via surgical procedures. Currently, a number of health disorders require prompt treatment that mostly include a surgical procedure. Thus, the growing number of surgical procedures is fueling up the global fibrin sealants market. According to World Health Organization statistics, millions of people undergo surgical treatment each year, with surgical intrusions accounting for approximately 13% of global total disability-adjusted life years (DALYs).
  • Upsurge in Hemophilia Cases – Hemophilia is a genetic bleeding ailment that causes the blood to clot improperly. This may result in both spontaneous bleeding and bleeding after injury or surgery. Therefore, it is anticipated to boost the market’s growth over the forecast period. As per the Centers for Disease Control and Prevention, the overall number of males living in the United States with hemophilia is approximated to be between 30,000 and 33,000.
  • Spiking Numbers of Orthopedic Surgeries – The main focus of orthopedic surgery, or orthopedics, is to care of the musculoskeletal system, which includes the skin as well as the bones, joints, ligaments, tendons, muscles, and nerves, and it is predicted to drive the growth of the global fibrin sealants market. Therefore, spiking number of orthopedic surgeries, including keyhole orthopedic surgery is anticipated to boost the market’s growth. For instance, in 2021, around 6.5 million orthopedic procedures were conducted in the United States.
  • Worldwide Increase in Geriatric Population - According to the figures released by the World Health Organization (WHO), the global population of people aged 60 and up is expected to increase from 1 billion in 2020 to 1.4 billion by 2030. The world's population of people aged 60 and over is predicted to double to 2.1 billion by 2050.
  • Increase in Global Healthcare Expenditure – Growing expenditure on global health by nations is bound to increase the revenue and size of the healthcare industry. According to World Bank data, worldwide healthcare expenditures increased by 9.83% in 2019.

Challenges

  • Associated Limitations of Fibrin Sealants in Minimally Invasive Surgeries- The market for fibrin sealants may see some difficulty during the forecast period owing to restrictions on the use of fibrin sealants in laparoscopic and minimally invasive surgeries. Additionally, the high expenses linked to treatment methods and the tight guidelines for product approvals may hinder sales development.
  • Disruption and Delays Caused by Supply Chains – Logistical issues created by supply chain disruptions can cause imbalances and shortages in the market. This can severely impact the demand for and sales of fibrin sealants.
  • Stringent Government Policies for Approval of Sealants

Fibrin Sealants Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

5.9%

Base Year Market Size (2024)

USD 1.01 billion

Forecast Year Market Size (2037)

USD 2.13 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4466
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of fibrin sealants is assessed at USD 1.06 billion.

The fibrin sealants market size was valued at USD 1.01 billion in 2024 and is expected to reach USD 2.13 billion by 2037, registering around 5.9% CAGR during the forecast period i.e., between 2025-2037. Worldwide growing count of surgical procedures, upsurge in hemophilia cases, spiking numbers of orthopedic surgeries, and worldwide increase in geriatric population will boost the market growth.

North America industry is likely to dominate majority revenue share of 45% by 2037, backed by significantly increasing healthcare expenditure, growing occurrence of cardiovascular diseases, and growing count of surgical procedures in the region.

The major players in the market include CSL Limited, Baxter International, Inc., Pfizer Inc., Asahi Kasei Corporation, Vivostat A/S, Octapharma AG
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample